17 Pembroke Street Upper
D02 AT22
Dublin 2
Ireland
353 1 661 9819
https://ovocabio.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 5
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Kirill Andreyevich Golovanov | Interim Chairman of the Board & CEO | 122.92k | N/A | 1978 |
Mr. Dmitriy Nikitashenko | Vice President of Finance | N/A | N/A | N/A |
Reneta Nikolova | Corporate Secretary | N/A | N/A | N/A |
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Ovoca Bio plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.